Session: 242. HAI: MRSA, MSSA, and Other Gram-positives Saturday, October 7, 2017: 12:30 PM Background. There is limited evidence to support whether contact precautions (CP) for MRSA-colonized patients in a Neonatal ICU (NICU) reduces rates of transmission, given current endemic MRSA. This study assesses rates of hospital-associated MRSA (HA-MRSA) in the NICU before and after discontinuation of CP for patients colonized with MRSA.
Background. Contact isolation of methicillin-resistant Staphylococcus aureus(MRSA) carriers is designed to "protect" non-carriers from MRSA infection. The Cleveland Clinic does not place MRSA carriers in contact isolation. The purpose of this study was to examine the value of contact isolation by comparing the risk of MRSA infection in MRSA carriers and non-carriers, in the absence of contact isolation.
Methods. Adult patients hospitalized at Cleveland Clinic from Jan 1, 2008 to December 31, 2015, who were tested for S. aureuscolonization by PCR or culture of a nasal swab at least once during the hospitalization were screened for inclusion. Only the first hospitalization per patient was considered. Included patients were divided into MRSA carriers and non-carriers, based on the result of their first nasal MRSA test result. Among these patients, the risk of subsequent MRSA bloodstream infection (BSI) and non-bacteremic MRSA infection during the same hospitalization were determined, and compared, for non-carriers vs. carriers.
Results. Of 74595 patients identified, 1223 were excluded because they had a S. aureus infection within 3 days of admission to the hospital. Of the remaining 73372 patients, 5% were MRSA carriers. One hundred and twenty (0.2%) of 69,452 non-carriers developed an MRSA infection during the same hospitalization compared with 82 (2.1%) of the 3,920 MRSA carriers (RR 0.08, ). Relative risks were very similar when analyzed separately for bacteremic and non-bacteremic infection. A Monte Carlo simulation with 1,000 trials simulating corrections for false positive and false negative nasal MRSA tests found very similar results. The magnitude of the effect was similar across subgroups of age, sex, year, and hospital length of stay (figure).
Conclusion. Non-carriers are at much lower risk of developing MRSA infection during a hospitalization than are MRSA carriers. The absolute risk of MRSA infection in non-carriers is one-fifth of 1%, even in the absence of "protection" by contact isolation of MRSA carriers. These findings suggest that the focus of preventing MRSA infections should be on protecting MRSA carriers, not the non-carriers. Figure: Relative Risk, across subgroups, of MSSA carriers developing MRSA infection compared with MRSA carriers. (MRSA) . The extent to which resident-to-resident transmission accounts for the high burden of MRSA in these facilities remains poorly understood. The objective of this study was to estimate the frequency of intra-facility MRSA acquisition in a sample of SNFs participating in a longitduinal study in Wisconsin.
Methods. MRSA colonization among a cohort of 449 subjects residing in six SNFs in Southern Wisconsin was measured using serial, multi-anatomical surveillance culturing. Phenotypic acquisitions events (i.e., MRSA [-] to MRSA[+]) were identified and further characterized both temporally (calendar date) and genetically (pulsefield gel electrophoresis). An intra-facility acquisition event was defined as incident recovery of an MRSA isolate that was genetically identical to at least one other strain previously recovered in a study facility. A Marascuilo procedure for comparing multiple proportions was employed to determine whether the proportion of intra-facility MRSA acquisitions differed across study facilities. Linear regression was employed to assess if certain facility-level characteristics were associated with rates of intra-facility MRSA acquisition.
Results. 129 acquisition events were identified that met our criteria, of which 74 were determined to be intra-facility (57.4%) [95% CI: 45.5-67.6%]. Statistically significant differences were found between the intra-facility acquisition proportion of multiple SNFs. A facility's baseline MRSA prevalence was significantly associated with its intra-facility MRSA acquisition rate (R 2 = 0.784, P-value = 0.012).
Conclusion. Intra-facility acquisition represents a large proportion of the burden of MRSA observed in SNFs. The rate of intra-facility acquisition is variable between facilities but may, in part, be explained by the prevalent burden of MRSA in the facility (i.e., MRSA colonization pressure to characteristics of the facility). Whether other facility characteristics, including infection prevention practices are contributing to these transmission dynamics requires further study.
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